Although no SNPs in KLK4 have been reported by GWAS to be associated with prostate cancer at genome-wide significance levels to date, commonly used GWAS chips only capture 22% [22] - 44% [23] of validated genetic variation in the locus with r2≥0.80. Here, KLK4 is linked to prostate carcinoma.